Literature DB >> 19398720

Participation of the urokinase receptor in neutrophil efferocytosis.

Young-Jun Park1, Gang Liu, Yuko Tsuruta, Emmanuel Lorne, Edward Abraham.   

Abstract

The urokinase receptor (uPAR) plays an important role in regulation of fibronolysis, cell migration, and adhesion. In this study, we examined whether uPAR plays a role in modulating efferocytosis of neutrophils. Macrophages from uPAR(-/-) mice demonstrated enhanced ability to engulf viable wild-type (WT) neutrophils in vitro and in vivo in the lungs. The increased phagocytic activity of uPAR(-/-) macrophages was abrogated by incubation with soluble uPAR (suPAR), arginine-glycine-aspartic acid (RGD)-containing peptides, or anti-integrin antibodies. There was increased uptake of viable uPAR(-/-) neutrophils by WT macrophages. Incubation of uPAR(-/-) neutrophils with suPAR or anti-integrin antibodies diminished uptake by WT macrophages to baseline. Uptake of uPAR(-/-) neutrophils by uPAR(-/-) macrophages was not enhanced. However, incubation of uPAR(-/-) neutrophils or uPAR(-/-) macrophages, but not both, with suPAR enhanced the uptake of viable uPAR(-/-) neutrophils by uPAR(-/-) macrophages. The adhesion of WT neutrophils to uPAR(-/-) macrophages was higher than to WT macrophages. uPAR(-/-) neutrophils demonstrated increased adhesion to suPAR, which was abrogated by blocking of low-density lipoprotein related protein and integrins. Expression of uPAR on the surface of apoptotic neutrophils was reduced compared with levels on viable neutrophils. These results demonstrate a novel role for uPAR in modulating recognition and clearance of neutrophils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398720      PMCID: PMC2716023          DOI: 10.1182/blood-2008-12-193524

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  Coming to grips with integrin binding to ligands.

Authors:  M Amin Arnaout; Simon L Goodman; Jian-Ping Xiong
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

Review 2.  Engulfment of apoptotic cells: signals for a good meal.

Authors:  Kodi S Ravichandran; Ulrike Lorenz
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

Review 3.  The urokinase receptor and integrins in cancer progression.

Authors:  C-H Tang; Y Wei
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

Review 4.  Apoptosis in the lung: induction, clearance and detection.

Authors:  P M Henson; R M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-04       Impact factor: 5.464

5.  Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alphaMbeta2 headpiece and reorientation of its transmembrane domains.

Authors:  Man-Li Tang; Ardcharaporn Vararattanavech; Suet-Mien Tan
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

6.  High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.

Authors:  Gang Liu; Jing Wang; Young-Jun Park; Yuko Tsuruta; Emmanuel F Lorne; Xia Zhao; Edward Abraham
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance.

Authors:  Seung-Yoon Park; So-Youn Kim; Mi-Yeon Jung; Dong-Jun Bae; In-San Kim
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

8.  PAI-1 inhibits neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Emmanuel F Lorne; Xia Zhao; Jing Wang; Yuko Tsuruta; Jaroslaw Zmijewski; Edward Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

9.  Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.

Authors:  Yashodhar P Bhandary; Thirunavukkarasu Velusamy; Praveenkumar Shetty; Rashmi S Shetty; Steven Idell; Douglas B Cines; Deepika Jain; Khalil Bdeir; Edward Abraham; Yuko Tsuruta; Sreerama Shetty
Journal:  Am J Respir Crit Care Med       Date:  2008-11-21       Impact factor: 21.405

10.  Modification of kidney barrier function by the urokinase receptor.

Authors:  Changli Wei; Clemens C Möller; Mehmet M Altintas; Jing Li; Karin Schwarz; Serena Zacchigna; Liang Xie; Anna Henger; Holger Schmid; Maria P Rastaldi; Peter Cowan; Matthias Kretzler; Roberto Parrilla; Moïse Bendayan; Vineet Gupta; Boris Nikolic; Raghu Kalluri; Peter Carmeliet; Peter Mundel; Jochen Reiser
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

View more
  25 in total

1.  High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.

Authors:  Aizhen Yang; Jihong Dai; Zhanli Xie; Robert W Colman; Qingyu Wu; Raymond B Birge; Yi Wu
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

2.  Kakkalide and its metabolite irisolidone ameliorate carrageenan-induced inflammation in mice by inhibiting NF-κB pathway.

Authors:  Sung-Won Min; Young-Jun Park; Dong-Hyun Kim
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression.

Authors:  Martin Hoenigl; Carlee B Moser; Nicholas Funderburg; Ronald Bosch; Amy Kantor; Yonglong Zhang; Jesper Eugen-Olsen; Malcolm Finkelman; Jochen Reiser; Alan Landay; Daniela Moisi; Michael M Lederman; Sara Gianella
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

4.  Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.

Authors:  Eun-Ha Joh; Dong-Hyun Kim
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.

Authors:  Yanping Yang; Arnaud Friggeri; Sami Banerjee; Khalil Bdeir; Douglas B Cines; Gang Liu; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

Review 6.  Clearance of apoptotic neutrophils and resolution of inflammation.

Authors:  Mallary C Greenlee-Wacker
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

7.  Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.

Authors:  Ayman Samman Tahhan; Salim S Hayek; Pratik Sandesara; Jamal Hajjari; Muhammad Hammadah; Wesley T O'Neal; Heval M Kelli; Ayman Alkhoder; Nima Ghasemzadeh; Yi-An Ko; Hiroshi Aida; Mohamad Mazen Gafeer; Naser Abdelhadi; Kareem Hosny Mohammed; Keyur Patel; Shipra Arya; Jochen Reiser; Viola Vaccarino; Laurence Sperling; Arshed Quyyumi
Journal:  Atherosclerosis       Date:  2017-06-08       Impact factor: 5.162

8.  Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages.

Authors:  Hong-Beom Bae; Jean-Marc Tadie; Shaoning Jiang; Dae Won Park; Celeste P Bell; Lawrence C Thompson; Cynthia B Peterson; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

9.  Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury.

Authors:  Agnieszka Krupa; Marek Fol; Moshiur Rahman; Karen Y Stokes; Jon M Florence; Igor L Leskov; Mikhail V Khoretonenko; Michael A Matthay; Kathleen D Liu; Carolyn S Calfee; Amy Tvinnereim; Gabriel R Rosenfield; Anna K Kurdowska
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-01       Impact factor: 5.464

10.  Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis.

Authors:  Mallary C Greenlee-Wacker; Kevin M Rigby; Scott D Kobayashi; Adeline R Porter; Frank R DeLeo; William M Nauseef
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.